Literature DB >> 11451946

Induction of apoptosis by protein inhibitor of activated Stat1 through c-Jun NH2-terminal kinase activation.

B Liu1, K Shuai.   

Abstract

Members of the protein inhibitor of activated signal transducer and activator of transcription (STAT) family (PIAS family) of proteins act as negative regulators of STATs in cytokine signaling. We report here that PIAS proteins have proapoptotic activity. PIAS1 induced apoptosis in both human 293T cells and human osteosarcoma U2OS cells. PIAS1 is localized in the nucleus as distinct nuclear dots. Ectopic expression of PIAS1 in U2OS cells activated JNK1 (c-Jun NH(2)-terminal kinase). A dominant-negative JNK1, capable of inhibiting PIAS1-induced JNK1 activation, blocked PIAS1-mediated apoptosis. Furthermore, a mutant PIAS1, lacking the first 9 amino acid residues, failed to repress Stat1-mediated gene activation although it retained its ability to activate JNK and to trigger apoptosis. Our results identify a novel function of PIAS1 in the induction of JNK-dependent apoptosis, independent of the previously known inhibitory activity of PIAS1 in STAT-mediated gene activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11451946     DOI: 10.1074/jbc.M101085200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.

Authors:  Guillaume Bossis; Cécile E Malnou; Rosa Farras; Elisabetta Andermarcher; Robert Hipskind; Manuel Rodriguez; Darja Schmidt; Stefan Muller; Isabelle Jariel-Encontre; Marc Piechaczyk
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

Review 2.  SUMO rules: regulatory concepts and their implication in neurologic functions.

Authors:  Mathias Droescher; Viduth K Chaugule; Andrea Pichler
Journal:  Neuromolecular Med       Date:  2013-08-30       Impact factor: 3.843

3.  Negative regulation of NF-kappaB signaling by PIAS1.

Authors:  Bin Liu; Randy Yang; Kelly A Wong; Crescent Getman; Natalie Stein; Michael A Teitell; Genhong Cheng; Hong Wu; Ke Shuai
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

4.  The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase.

Authors:  Olivier Kirsh; Jacob-S Seeler; Andrea Pichler; Andreas Gast; Stefan Müller; Eric Miska; Marion Mathieu; Annick Harel-Bellan; Tony Kouzarides; Frauke Melchior; Anne Dejean
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

5.  Targeting radioresistant osteosarcoma cells with parthenolide.

Authors:  Daniel Zuch; An-Hoa Giang; Yuriy Shapovalov; Edward Schwarz; Randy Rosier; Regis O'Keefe; Roman A Eliseev
Journal:  J Cell Biochem       Date:  2012-04       Impact factor: 4.429

6.  The SUMO ligase PIAS1 regulates UV-induced apoptosis by recruiting Daxx to SUMOylated foci.

Authors:  Raghavi Sudharsan; Yoshiaki Azuma
Journal:  J Cell Sci       Date:  2012-09-12       Impact factor: 5.285

7.  Inhibition of AP-1 transcriptional activity blocks the migration, invasion, and experimental metastasis of murine osteosarcoma.

Authors:  Virna D Leaner; Jeffrey F Chick; Howard Donninger; Ilona Linniola; Arnulfo Mendoza; Chand Khanna; Michael J Birrer
Journal:  Am J Pathol       Date:  2008-12-12       Impact factor: 4.307

Review 8.  Principles of interleukin (IL)-6-type cytokine signalling and its regulation.

Authors:  Peter C Heinrich; Iris Behrmann; Serge Haan; Heike M Hermanns; Gerhard Müller-Newen; Fred Schaper
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

Review 9.  Epigenetic regulation of signal transducer and activator of transcription 3 in acute myeloid leukemia.

Authors:  Sampa Ghoshal Gupta; Heinz Baumann; Meir Wetzler
Journal:  Leuk Res       Date:  2008-01-14       Impact factor: 3.156

10.  The SUMO E3-ligase PIAS1 couples reactive oxygen species-dependent JNK activation to oxidative cell death.

Authors:  Beatriz B Leitao; Marius C Jones; Jan J Brosens
Journal:  FASEB J       Date:  2011-06-15       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.